Search

Your search keyword '"Morel, Macarena"' showing total 17 results
Start Over Author "Morel, Macarena"
17 results on '"Morel, Macarena"'

6. Resumen SUPPORT de una revisión sistemática : Percepciones y experiencias de los profesionales sanitarios sobre la utilización de tecnologías de salud móvil (mHealth) para la prestación de servicios de atención primaria de salud: una síntesis de evidencia cualitativa. Satellite Cochrane EPOC-CHILE

Author

Pantoja, Tomás, Morel, Macarena, and Ortiz-Muñoz, Luis

Abstract

La ‘Salud móvil’ (mHealth) se refiere a los cuidados de saludapoyados por el uso de dispositivos móviles (como teléfonos móviles y tabletas). En la atención primaria de salud, los profesionales de la salud a menudo usan dispositivos móviles para registrar usuarios, rastrear su estado de salud y tomar decisiones respecto de su cuidado, así como para comunicarse con ellos y con otros profesionales de la salud. Saber cómo los profesionales de salud se relacionan y experimentan este tipo de tecnología puede ayudar en suimplementación.

Published
2022
Full Text
View/download PDF

8. Therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis: Protocol for a systematic review

Author

Schulze, Clara, Durán, Josefina, Bravo-Jeria, Rocío, Verdugo-Paiva, Francisca, Morel, Macarena, and Rada, Gabriel

Subjects
Protocol (science), Research ethics, medicine.medical_specialty, biology, business.industry, education, MEDLINE, medicine.disease, biology.organism_classification, Placebo, law.invention, Randomized controlled trial, law, Rheumatoid arthritis, Synthetic cannabinoids, medicine, Cannabis, business, Intensive care medicine, medicine.drug
Abstract

OBJECTIVETo assess the therapeutic effects of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis.DESIGNThis is the protocol of a systematic review. DATA SOURCES: Searches will be conducted in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), trial registries, grey literature and in a centralized repository in L-OVE (Living OVerview of Evidence). L-OVE is a platform that maps PICO questions to evidence from Epistemonikos database.ELIGIBILITY CRITERIA FOR SELECTING STUDIES AND METHODSWe will include randomized controlled trials evaluating therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis. Our primary interest will be in trials comparing the intervention with placebo or no treatment (intervention plus optimal treatment vs placebo plus optimal treatment or optimal treatment alone) in patients receiving optimal treatment for rheumatoid arthritis. Optimal treatment will be defined as disease modifying anti-rheumatic drugs. Two reviewers will independently screen each study for eligibility, extract data, and assess the risk of bias. We will perform random-effects meta-analyses and use Grading of Recommendations Assessment, Development and Evaluation (GRADE) to assess the certainty of the evidence for each outcome.ETHICS AND DISSEMINATIONThe Scientific Ethics Committee of the Pontificia Universidad Católica de Chile granted ethical exemption for the realization of this study. Results of this review will be widely disseminated via peer-reviewed publications, social networks and traditional media and will be sent to relevant international organizations discussing this topic.

Published
2020

9. Resumen SUPPORT de una revisión sistemática : Videollamadas para reducir el aislamiento social y la soledad en las personas mayores: una revisión rápida

Author

Morel, Macarena, Ortiz-Muñoz, Luis, and Pantoja, Tomás

Abstract

En el contexto de la pandemia de COVID-19, muchos países han introducido restricciones de movimiento para limitar la diseminación del virus. Dichas restricciones pudieran provocar una mayor soledad y aislamiento social entre los ancianos, lo que pudiera llevar a un deterioro de su salud mental y física. La videotelefonía puede ayudar a que este grupo poblacional a mantenerse conectado durante la crisis actual al expandir sus círculos sociales o aumentar la frecuencia de contacto con conocidos.

Published
2020

10. Resumen SUPPORT de una revisión sistemática : Cuarentena sola o en combinación con otras medidas de salud pública para controlar el COVID‐19: una revisión rápida. Satellite Cochrane EPOC-CHILE

Author

Ortiz-Muñoz, Luis, Pantoja, Tomás, and Morel, Macarena

Abstract

La enfermedad por coronavirus 2019 (COVID‐19) es una enfermedad de aparición rápida que ha sido clasificada como pandemia por la Organización Mundial de la Salud (OMS). Actualmente no existe un tratamiento o vacuna efectiva para la enfermedad y una de las medidas recomendadas por la OMS es la cuarentena.

Published
2020

17. Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence.

Author

Schulze-Schiappacasse C, Durán J, Bravo-Jeria R, Verdugo-Paiva F, Morel M, and Rada G

Subjects
Analgesics therapeutic use, Humans, Treatment Outcome, Arthritis, Rheumatoid drug therapy, Cannabinoids adverse effects, Cannabis
Abstract

Background: Symptom management in rheumatoid arthritis (RA) remains a complex challenge. Widespread use of cannabis-based medicines for a myriad of symptoms has fostered rheumatology patients' interest. However, their safety and efficacy in RA remain unclear., Objective: The aim of this study was to perform a structured summary of the body of evidence in order to determine whether cannabis, cannabis-derived products, and synthetic cannabinoids are an effective treatment for rheumatoid arthritis., Methods: An electronic search in Epistemonikos database was performed to identify systematic reviews and their primary studies that addressed our clinical question. The body of evidence was collected in a pivot table in Epistemonikos. Information and data from the primary studies were extracted from the identified reviews. Finally, extracted data were reanalyzed, and a summary of findings table was generated using the Grading of Recommendations Assessment, Development and Evaluation approach., Results: Twenty-six systematic reviews were identified which included in total only 1 randomized trial assessing our clinical question., Conclusions: Cannabis, cannabis-derived products and synthetic cannabinoids may slightly reduce disease activity in patients with RA. Its use may result in little to no difference in pain reduction and may slightly increase nervous system adverse events. The evidence is very uncertain about the effect of cannabis, cannabis-derived products, and synthetic cannabinoids on serious adverse events risk., Competing Interests: The authors declare no conflict of interest., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results